|
In this episode of Medtech Snapshot we're joined by SPARK Neuro COO Marinela Gombosev as we sort through the opportunities and challenges in adopting machine learning (ML) and artificial intelligence (AI) technologies in the medical device space. Listen in as Marinela provides additional perspective on the considerations for adopting this technology within our current health system and its stakeholders like the FDA, clinicians, etc.
Enjoying these quick 3-minute discussions? Be sure to check out our past Medtech Snapshot episodes at https://lnkd.in/gFwF9GYN #medtechsnapshot #medtech #snapshot #AI #machinelearning #medicaldevice #artificialintelligence #fda #healthcare
0 Comments
Our LinkedIn poll concluded with some interesting findings and a fair amount of debate. It's estimated 75% of medical device start-ups fail or never make it to the market. Understanding the primary factors which drive these outcomes makes or breaks the difference in a start-ups success. As our respondents weighed in it was clear the primary factor which gets in the way of a start-up meeting up with success is in fact its own people. 48% of voters identified this as the primary reason for failure, many of which current have or have had in the past direct experience operating in a management role within start-ups.  The debate ragged on within the poll as some people felt like the product (ie technology) played a larger part in the failure of the company as it's ability to meet a core, and perhaps large, clinical need drove a variety of things including funding, market acceptance, etc. In the end the old saying still rings true - the people we surround ourselves with makes all the difference.  Imagine a life that is totally different from the one we know today. A life where disease and medical disorders are not commonplace. A life where medical afflictions no longer claim lives. It’s a wild thought, we know. It is our utopia!
Now think about this utopia in comparison to where we are at today. In 2019, roughly 58 million people died worldwide of which 74% of those deaths (or 43 million people) were the result of noncommunicable diseases like heart disease, stroke and COPD. |
About the AuthorTravis Smith is the founder and managing director of Square-1 Engineering, a medical device consulting firm, providing end to end engineering and compliance services. He successfully served the life sciences marketplace in SoCal for over 15 years and has been recognized as a ‘40 Under 40’ honoree by the Greater Irvine Chamber of Commerce as a top leader in Orange County, CA. |
RSS Feed
